Tianshui Zhongxing Bio-technology Co.,Ltd.

SZSE:002772 주식 보고서

시가총액: CN¥2.7b

Tianshui Zhongxing Bio-technologyLtd 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Tianshui Zhongxing Bio-technologyLtd.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Food 수익 성장22.1%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

Nov 02
Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think

These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Oct 01
These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong

Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

May 12
Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30

Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

Mar 15
Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Tianshui Zhongxing Bio-technologyLtd 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

SZSE:002772 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
9/30/20241,89573217417N/A
6/30/20241,827-8188358N/A
3/31/20241,795-4181341N/A
12/31/20231,931160395502N/A
9/30/20231,978216400537N/A
6/30/20232,130376528686N/A
3/31/20232,105342411627N/A
1/1/20231,970158248494N/A
9/30/20221,94222235-221N/A
6/30/20221,71122-436-389N/A
3/31/20221,64926-663-382N/A
12/31/20211,55655-700-414N/A
9/30/20211,50819-506338N/A
6/30/20211,554145-261320N/A
3/31/20211,51215810345N/A
12/31/20201,48318910389N/A
9/30/20201,422150-81339N/A
6/30/20201,28075-116360N/A
3/31/20201,21576-232368N/A
12/31/20191,15668-304359N/A
9/30/20191,01045-331285N/A
6/30/20191,021127-384346N/A
3/31/201996791-420274N/A
12/31/2018926112-420232N/A
9/30/2018910143-458235N/A
6/30/2018835113N/A196N/A
3/31/2018839180N/A251N/A
12/31/2017740142N/A207N/A
9/30/2017683144N/A233N/A
6/30/2017639147N/A215N/A
3/31/2017571122N/A185N/A
12/31/2016585159N/A233N/A
9/30/2016575167N/A227N/A
6/30/2016539151N/A226N/A
3/31/2016533154N/A245N/A
12/31/2015480114N/A209N/A
9/30/2015444102N/A190N/A
6/30/201542595N/A170N/A
3/31/201539986N/A169N/A
12/31/201438391N/A170N/A
12/31/201326455N/A93N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if 002772's forecast earnings growth is above the savings rate (2.9%).

수익 vs 시장: Insufficient data to determine if 002772's earnings are forecast to grow faster than the CN market

고성장 수익: Insufficient data to determine if 002772's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if 002772's revenue is forecast to grow faster than the CN market.

고성장 수익: Insufficient data to determine if 002772's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if 002772's Return on Equity is forecast to be high in 3 years time


성장 기업 발견